Stock Expert AI

Regeneron Pharmaceuticals, Inc. (REGN) Stock Forecast & Price Target

The FMP analyst consensus price target for REGN is $844.26 (median $850.00; range $737.00 to $1030.00), captured Oct 4, 2026. Coverage: 18 analysts contributing to the forward estimates (FMP), captured Oct 4, 2026.

REGN analyst price target

Consensus (mean) target$844.26as of Oct 4, 2026
Median target$850.00as of Oct 4, 2026
High target$1030.00as of Oct 4, 2026
Low target$737.00as of Oct 4, 2026

Source: FMP price-target consensus · Captured Oct 4, 2026.

Coverage: 18 analysts contributing to the forward estimates (FMP) · captured Oct 4, 2026.

Price and implied move

Last stored price$735.20as of Oct 2, 2026

The same stored quote the REGN stock page shows, dated to its trading session.

Implied move to consensus (calculated): +14.8%

(Consensus $844.26, captured Oct 4, 2026, minus last stored price $735.20, as of the Oct 2, 2026 trading session) ÷ last stored price. Arithmetic on two stored figures, not a prediction.

Frequently asked questions

What is the REGN price target?

The FMP analyst consensus price target for REGN is $844.26 (median $850.00; range $737.00 to $1030.00), captured Oct 4, 2026. Coverage: 18 analysts contributing to the forward estimates (FMP), captured Oct 4, 2026.

Is the REGN consensus target pulled by outliers?

In FMP's consensus captured Oct 4, 2026, the mean (consensus) target for REGN is $844.26 and the median is $850.00: the mean is 0.7% below the median, so lower targets pull the average down.

How far is the REGN consensus target from the current price?

Against the last stored price of $735.20 (as of the Oct 2, 2026 trading session), the consensus implies a move of +14.8%. That figure is arithmetic on those two stored numbers, not a prediction. The target was captured Oct 4, 2026.

Full REGN stock analysis →

This is educational content, not investment advice. Past performance does not guarantee future results.